These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29341911)

  • 1. An efficient PEGylated gene delivery system with improved targeting: Synergism between octaarginine and a fusogenic peptide.
    Khalil IA; Harashima H
    Int J Pharm; 2018 Mar; 538(1-2):179-187. PubMed ID: 29341911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
    Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between a cell penetrating peptide and a pH-sensitive cationic lipid in efficient gene delivery based on double-coated nanoparticles.
    Khalil IA; Kimura S; Sato Y; Harashima H
    J Control Release; 2018 Apr; 275():107-116. PubMed ID: 29452131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
    Khalil IA; Hayashi Y; Mizuno R; Harashima H
    J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
    Yamada Y; Hashida M; Harashima H
    Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery.
    Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H
    J Control Release; 2011 Jul; 153(2):141-8. PubMed ID: 21447361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
    Kibria G; Hatakeyama H; Harashima H
    Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stearylated INF7 peptide enhances endosomal escape and gene expression of PEGylated nanoparticles both in vitro and in vivo.
    El-Sayed A; Masuda T; Akita H; Harashima H
    J Pharm Sci; 2012 Feb; 101(2):879-82. PubMed ID: 22086751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
    Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
    Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
    Toriyabe N; Hayashi Y; Harashima H
    Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GALA-Modified Lipid Nanoparticles for the Targeted Delivery of Plasmid DNA to the Lungs.
    Hagino Y; Khalil IA; Kimura S; Kusumoto K; Harashima H
    Mol Pharm; 2021 Mar; 18(3):878-888. PubMed ID: 33492961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles.
    Moore NM; Sheppard CL; Barbour TR; Sakiyama-Elbert SE
    J Gene Med; 2008 Oct; 10(10):1134-49. PubMed ID: 18642401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine-induced hepatitis.
    Hayashi Y; Mizuno R; Ikramy KA; Akita H; Harashima H
    Nucleic Acid Ther; 2012 Oct; 22(5):360-3. PubMed ID: 22963044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
    El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
    J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives.
    Sasaki K; Kogure K; Chaki S; Nakamura Y; Moriguchi R; Hamada H; Danev R; Nagayama K; Futaki S; Harashima H
    Anal Bioanal Chem; 2008 Aug; 391(8):2717-27. PubMed ID: 18351325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.
    Liu X; Liu C; Zhang W; Xie C; Wei G; Lu W
    Int J Pharm; 2013 May; 448(1):159-67. PubMed ID: 23538098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
    Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
    Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.